pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,063 phase readout · 5,000 device 510k · 4,728 grant · 2,469 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • phase readout5,063
  • device 510k5,000
  • grant4,728
  • 8k filing2,469
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • pdufa319
  • therapy area
    • Ophthalmology5

    Week of Sep 23, 2002

    3
    ›Sep 26, 2002approval8707d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 27, 2002approval8706d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 27, 2002approval8706d agoTHALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE TL-201) — FDA approval

    Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗

    Week of Sep 30, 2002

    5
    ›Oct 1, 2002approval8702d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Oct 1, 2002approval

    Week of Oct 7, 2002

    6
    ›Oct 7, 2002approval8696d agoFENTANYL CITRATE — FDA approvalEffentora

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Effentora →fda approvals ↗
    ›Oct 9, 2002approval

    Week of Oct 14, 2002

    3
    ›Oct 15, 2002approval8688d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Oct 17, 2002approval

    Week of Oct 21, 2002

    12
    ›Oct 21, 2002approval8682d agoSOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) — FDA approvalmethylprednisolone sodium succinate

    Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION

    full page →methylprednisolone sodium succinate →fda approvals ↗
    ›Oct 21, 2002

    Week of Oct 28, 2002

    4
    ›Oct 28, 2002approval8675d agoPROSCAR (FINASTERIDE) — FDA approvalPROSCAR

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →PROSCAR →fda approvals ↗
    ›Oct 29, 2002approval

    Week of Nov 4, 2002

    12
    ›Nov 4, 2002approval8668d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 5, 2002approval

    Week of Nov 11, 2002

    3
    ›Nov 13, 2002approval8659d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Nov 14, 2002approval

    Week of Nov 18, 2002

    2
    ›Nov 18, 2002approval8654d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Nov 20, 2002approval
    ← prev
    page 78 of 380
    next →
    8702d ago
    CARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Oct 2, 2002approval8701d agoWELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 2, 2002approval8701d agoWELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 3, 2002approval8700d agoULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approvalremifentanil hydrochloride

    Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION

    full page →remifentanil hydrochloride →fda approvals ↗
    8694d ago
    CEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Oct 9, 2002approval8694d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: PLIVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 9, 2002approval8694d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Oct 9, 2002approval8694d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Oct 11, 2002approval8692d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    8686d ago
    BUTORPHANOL TARTRATE — FDA approvalBUTORPHANOL TARTRATE

    Sponsor: RISING. Form: SPRAY, METERED. Route: NASAL

    full page →BUTORPHANOL TARTRATE →fda approvals ↗
    ›Oct 18, 2002approval8685d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    approval
    8682d ago
    ERRIN (NORETHINDRONE) — FDA approvalNaari USA Inc

    Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL-28

    full page →fda approvals ↗
    ›Oct 22, 2002approval8681d agoWELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 22, 2002approval8681d agoWELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 24, 2002approval8679d agoCARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NICARDIPINE HYDROCHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 25, 2002approval8678d agoLIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE) — FDA approvalLaryng-O-Jet

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Laryng-O-Jet →fda approvals ↗
    ›Oct 25, 2002approval8678d agoBUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalBUTORPHANOL TARTRATE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →BUTORPHANOL TARTRATE →fda approvals ↗
    ›Oct 25, 2002approval8678d agoNUBAIN (NALBUPHINE HYDROCHLORIDE) — FDA approvalTrevi Therapeutics, Inc.

    Sponsor: PH HEALTH. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 25, 2002approval8678d agoNALBUPHINE HYDROCHLORIDE — FDA approvalNALBUPHINE HYDROCHLORIDE

    Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →NALBUPHINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 2002approval8678d agoNALBUPHINE HYDROCHLORIDE — FDA approvalNALBUPHINE HYDROCHLORIDE

    Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →NALBUPHINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 25, 2002approval8678d agoFENTANYL CITRATE — FDA approvalEffentora

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Effentora →fda approvals ↗
    ›Oct 25, 2002approval8678d agoMEDROL (METHYLPREDNISOLONE) — FDA approvalMEDROL

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    8674d ago
    TRAMADOL HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2002approval8673d agoTRAMADOL HYDROCHLORIDE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2002approval8673d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    8667d ago
    DEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Nov 5, 2002approval8667d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Nov 5, 2002approval8667d agoBUPROPION HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 5, 2002approval8667d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    ›Nov 5, 2002approval8667d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

    Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

    full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Nov 5, 2002approval8667d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2002approval8666d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2002approval8666d agoMETADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    ›Nov 6, 2002approval8666d agoMETADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    ›Nov 7, 2002approval8665d agoOXAPROZIN — FDA approvalSolubiomix LLC

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 8, 2002approval8664d agoAMNESTEEM (ISOTRETINOIN) — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    8658d ago
    VALPROATE SODIUM — FDA approvalVALPROATE SODIUM

    Sponsor: SAGENT. Form: INJECTABLE. Route: INJECTION

    full page →VALPROATE SODIUM →fda approvals ↗
    ›Nov 14, 2002approval8658d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

    Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    8652d ago
    METHYLPREDNISOLONE — FDA approvalMEDROL

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    $OGN13.52-0.15%
    $ABBV263.20+2.45%
    $ASPU0.2893-0.26%
    $AMRX18.76+3.70%
    $ABBV263.20+2.45%
    $TRVI
    $AMRX18.76+3.70%
    $PFE25.25+2.35%
    $ASPU0.2893-0.26%
    $PFE25.25+2.35%
    $AYTU2.2300-0.89%
    $AYTU2.2300-0.89%